News

SAVELLA (Milnacipran) 12.5mg, 25mg, 50mg, 100mg tablets by Forest and Cypress

Profiles the new serotonin and norepinephrine reuptake inhibitor indicated for fibromyalgia.

MOZOBIL (Plerixafor) 20mg/mL solution for SC inj by Genzyme

Profiles Mozobil (plerixafor injection), for use in patients with non-Hodgkin’s lymphoma or multiple myeloma to mobilize hematopoietic stem cells in advance of autologous transplantation.

PROMACTA (Eltrombopag) 25mg, 50mg tablets by GlaxoSmithKline

A profiles of Promacta (eltrombopag), for the treatment of thrombocytopenia due to chronic immune (idiopathic) thrombocytopenic purpura (ITP) in adults who have had an insufficient response to corticosteroids, immunoglobulins, or splenectomy.

Sancuso patch approved for nausea and vomiting

A profile of Sancuso (granisetron), an antiemetic (5-HT3 receptor blocker) indicated for prevention of nausea and vomiting in patients receiving moderately and/or highly emetogenic chemotherapy regimens of up to 5 consecutive days duration.

Relistor approved for OIC

A profiles of Relistor (methylnaltrexone bromide), an opioid antagonist (peripheral) indicated for opioid-induced constipation.

Totect

A profile of Totect (dexrazoxane), a topoisomerase II inhibitor/chelating agent used to treat extravasation resulting from IV anthracycline chemotherapy.

A profile of Torisel (temsirolimus), an antineoplastic agent indicated for advanced renal cell carcinoma.